Mobile

This clinical study evaluates and compares the efficacy and safety of Regorafenib versus placebo in patients with coloreactal cancer after curative resection of liver metastasis and completion of all ...

Update Il y a 4 ans
Reference: EUCTR2012-004369-42

This clinical study evaluates and compares the efficacy and safety of Regorafenib versus placebo in patients with coloreactal cancer after curative resection of liver metastasis and completion of all planned chemotherapy

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate and compare the efficacy and safety of regorafenib versus placebo in subjects with colorectal cancer (CRC) after curative resection of liver metastasis and completion of all planned chemotherapy.

Inclusion criteria

  • Metastatic colorectal cancer

Links